Doctor profile · Federal record

Dr. Blake Helget, M.D.

Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Internal Medicine Physician · Omaha, NE

  • NPI 1902288707
  • Accepts Medicare
  • MIPS 91.2 / 100 · 2023
  • 11 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
7911 W Center RD
Omaha, NE 68124
(402) 390-0333
fax (402) 390-9632

Credentials & registration

NPPES · NUCC
NPI registered
June 2015 — 11 yrs on file
Profile last updated
August 14, 2019
Year of graduation
2015 — 11 yrs since
Specialty taxonomy
207N00000X — NUCC code
State licenses (3)
Nebraska #31653 · New Jersey #31653 · Nebraska #7473

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1902288707. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
4,646
Distinct HCPCS
10
Medicare allowed
$250,990
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 1,439 267 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 656 456 $85
88305 Pathology examination of tissue using a microscope, intermediate complexity 528 331 $36
17000 Destruction of precancer skin growth, 1 growth 483 340 $47
11102 Biopsy of related skin growth, first growth 426 342 $88
99214 Established patient office or other outpatient visit, 30-39 minutes 230 171 $119
11103 Biopsy of related skin growth, each additional growth 218 121 $46
17110 Destruction of skin growth, 1-14 growths 151 125 $101
99203 New patient office or other outpatient visit, 30-44 minutes 75 75 $103
99212 Established patient office or other outpatient visit, 10-19 minutes 67 62 $53

In context: peer comparison

Among 12 peers in this city , average services per provider: 148. This provider delivers 31× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$449
Transactions
29
Manufacturers
10
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 14 $160.93
Galderma Laboratories, L.P. 3 $51.28
Incyte Corporation 2 $44.34
GENZYME CORPORATION 2 $44.00
Regeneron Healthcare Solutions, Inc. 2 $39.91
Lilly USA, LLC 2 $31.32
LEO Pharma Inc. 1 $23.47
UCB, Inc. 1 $23.05
E.R. Squibb & Sons, L.L.C. 1 $16.60
Arcutis Biotherapeutics, Inc. 1 $13.86

By nature of payment

Food and Beverage
$440
Education
$8

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
681
Patients
400
Total drug cost
$195,301
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 107 75 $1,322
Ketoconazole Generic 102 62 $2,966
Hydrocortisone Generic 68 56 $395
Clobetasol Propionate Generic 59 36 $5,831
Doxycycline Hyclate Generic 53 25 $1,183
Mometasone Furoate Generic 51 32 $1,349
Mupirocin Generic 47 39 $392
Dupixent Pen (Dupilumab) Brand 45 0 $175,053
Cephalexin Generic 35 31 $175
Clindamycin Phosphate Generic 27 18 $1,395

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Blake Helget's medical specialty?
Dr. Blake Helget practices Dermatology Physician in Omaha, NE.
Where does Dr. Blake Helget practice?
Dr. Blake Helget practices at 7911 W Center RD, Omaha, NE 68124. Office phone: 4023900333.
What is Dr. Blake Helget's NPI?
Dr. Blake Helget's National Provider Identifier (NPI) is 1902288707, issued by NPPES.
Does Dr. Blake Helget accept Medicare assignment?
Yes. Dr. Blake Helget accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Blake Helget commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Pathology examination of tissue using a microscope, intermediate complexity (HCPCS 88305). Source: CMS Medicare Physician & Other Practitioners file.